Pentraxin-3 as a Marker of Advanced Atherosclerosis Results from the Bruneck, ARMY and ARFY Studies-Reference-Cited by-同舟云学术

Pentraxin-3 as a Marker of Advanced Atherosclerosis Results from the Bruneck, ARMY and ARFY Studies

Published:2012-02-03 Issue:2 Volume:7 Page:e31474
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Knoflach Michael,Kiechl Stefan,Mantovani Alberto,Cuccovillo Ivan,Bottazzi Barbara,Xu Qingbo,Xiao Qingzhong,Gasperi Arno,Mayr Agnes,Kehrer Marlene,Willeit Johann,Wick Georg

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Atherosclerosis–an inflammatory disease.;R Ross;N Engl J Med,1999

2. Innate and adaptive immunity in the pathogenesis of atherosclerosis.;GK Hansson;Circ Res,2002

3. Autoimmune and Inflammatory Mechanisms in Atherosclerosis.;G Wick;Annu Rev Immunol,2004

4. An integrated view of humoral innate immunity: pentraxins as a paradigm.;B Bottazzi;Annu Rev Immunol,2010

5. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans.;G Peri;Circulation,2000

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pentraxin 3 as a marker of development and severity of stable coronary artery disease;Advances in Medical Sciences;2024-09

2. Circulating biomarkers in familial cerebral cavernous malformation;eBioMedicine;2024-01

3. Biomarkers to monitor the prognosis, disease severity, and treatment efficacy in coronary artery disease;Expert Review of Cardiovascular Therapy;2023-10-03

4. Role of the renin–angiotensin system in the pathophysiology of coronary heart disease and heart failure: Diagnostic biomarkers and therapy with drugs and natural products;Frontiers in Physiology;2023-02-23

5. Long Pentraxin 3 as a New Biomarker for Diagnosis of Hip and Knee Periprosthetic Joint Infections;Journal of Clinical Medicine;2023-01-29